RxSight, Inc.
RXST
$6.26
-$0.23-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.48% | -9.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.48% | -9.80% | |||
| Cost of Revenue | 20.15% | -27.63% | |||
| Gross Profit | 4.28% | -3.82% | |||
| SG&A Expenses | 1.30% | -5.63% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.36% | -10.75% | |||
| Operating Income | 6.91% | 13.03% | |||
| Income Before Tax | 6.72% | 16.57% | |||
| Income Tax Expenses | -50.00% | -68.75% | |||
| Earnings from Continuing Operations | 6.76% | 16.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.76% | 16.71% | |||
| EBIT | 6.91% | 13.03% | |||
| EBITDA | 7.40% | 14.33% | |||
| EPS Basic | 7.22% | 17.18% | |||
| Normalized Basic EPS | 7.22% | 17.03% | |||
| EPS Diluted | 7.22% | 17.18% | |||
| Normalized Diluted EPS | 7.22% | 17.03% | |||
| Average Basic Shares Outstanding | 0.51% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||